The Epilepsy Foundation supports a series of grants and fellowships to advance the understanding of epilepsy that will lead to better treatment, more effective prevention, and ultimately to a cure. Funding is available to researchers at all professional levels including students, junior investigators and established investigators.


Please note that the Epilepsy Foundation Patent and Copyright Policy applies primarily to awards offered to academic institutions and is open to clarification as needed. Commercial companies that are offered funding to support their research will have the opportunity to negotiate a suitable agreement with the Foundation regarding intellectual property rights as needed.

Fall 2015

Spring 2016

For researchers intending to apply for funding, please download the information and instructions for each program listed below.

Targeted Research Initiative for Research Regarding Cannabidiol and Epilepsy

The Targeted Research Initiative for Research Regarding Cannabidiol and Epilepsy recognizes the increasing need for research regarding Cannabidiol.  The purpose is to generate pilot data that can lead to sponsored research projects in the future.  The Foundation invites research grant applications from interested investigators to conduct pilot research in the following areas.  Projects should address at least one of the following numbered items and priority will be given to those that address at least one of the bulleted topics.  1. Fundamental knowledge of mechanism of action of Cannabidiol; 2. Fundamental knowledge of the consistency of products; 3. Cannabidiol therapeutics: *special interactions among AEDs and Cannabidiol, and *interactions of AEDs with epilepsy-associated, interictal dysfunctions of mood, anxiety and thought in those; and 4. Data base study.

Epilepsy Shark Tank Competition 2016

  • Application Deadline: November 13, 2015
  • Award Amount: up to $200,000 total

The Epilepsy Therapy Project, an initiative of the Epilepsy Foundation, is inviting entries that represent the most innovative new ideas in epilepsy treatment and care for its fifth annual Shark Tank Competition. The winner(s) of the 2016 Shark Tank Competition will receive international recognition and compete for awards totaling $200,000 to support the development and commercialization of an important new product, technology or therapeutic concept to help people with epilepsy.

Learn more about the Epilepsy Shark Tank Competition

Clinical Research Apprenticeships/Fellowships

The Epilepsy Foundation and the American Epilepsy Society announce changes to their Fellowship and Junior Investigator grant programs.

The Epilepsy Foundation and the American Epilepsy Society have each recently completed significant strategic planning efforts.  Both organizations have affirmed their commitment to supporting early career researchers, and are announcing modifications to their respective funding programs reflecting their organizational focus.

For the 2015-2016 cycle, AES will provide funding for pre- and post-doctoral basic and clinical fellowships and Junior Investigator grants and EF will provide funding for clinical fellowship and new investigator awards under the following schedule:

November 6, 2015

Letters of Intent due

December 4-7, 2015

Opportunity for applicants to meet with mentors at AES meeting to discuss submissions

February 15, 2016

Applications due

April 1, 2016

Awards announced

The change in submission deadlines has been made in response to feedback from grant recipients and applicants to better align with the timing of fellowship appointments. In addition, this schedule will facilitate mentorship and applicant support resources through the AES Annual Meeting and other mechanisms.

Apply for the Pre-doctoral Research Training Fellowships, Post-doctoral Research Training Fellowships, Research Training Fellowship for Clinicians, the Junior Investigator Research Grant, and other AES funding opportunities.

Epilepsy Foundation Clinical Research Apprenticeship
Letters of Intent due 11/6/15

The Epilepsy Foundation will support two one-year mentored awards in the amount of $25,000 for one year for salary (at least 30% effort) plus $10,000/year towards classwork and travel to appropriate meetings.  Applicants should be accepted into an epilepsy fellowship at a level 3 or 4 epilepsy center in the United States and may apply for either their first or second year of fellowship. Applicants must seek out a program that is actively involved in a large clinical research endeavor in epilepsy, identify a mentor who is involved in the project, and identify a role in the project that will lead to a publication or independent scholarship related to the project. The individualized training program proposed may consist of both didactic training and a supervised research experience designed to develop knowledge and skills in the chosen area of research and foster the career goals of the candidate. This fellowship program may also be a way for awardees to develop sufficient scientific skills and preliminary data to compete successfully for longer term support (e.g., grants from the NIH). Awardees will be expected to participate in the AES EpiPORT (Epilepsy-Patient Oriented Research Training) program and to attend the Pipeline or AEDD meeting and the AES Annual Meeting and Fellows Program. 

AES Clinical Research Fellowship

The AES Clinical Research Fellowship provides one year of mentored support for qualified individuals who intend to pursue patient-oriented clinical research in epilepsy, including epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research. Applicants may be epilepsy fellows, postdoctoral fellows, or newly appointed junior faculty and should propose a research project and training program designed to develop clinical and scientific skills and preliminary data in preparation for an independent research career. This award provides up to $50,000 for stipend (at least 50% effort) and travel support for one year. The number of awards granted each year is contingent upon available funds.

More information about this program, including how to apply, is available at the American Epilepsy Society website.

New Therapy Commercialization Grants Program

Application deadline: LOIs due March 7, 2016

Instructions and Guidelines

The Epilepsy Foundation - New Therapy Commercialization Grants Program supports the development of more effective therapies by serving as a catalyst for moving innovative therapies from the laboratory to the patient. Investigators must hold a relevant advanced degree (M.D., and/or Ph.D.), and have completed all research training. This call for proposals is open to investigators at corporations as well as the academic/university arena.

For the New Therapy–Commercialization Grants, the Epilepsy Foundation encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. These matching funds seek to leverage other resources, and accelerate the pace of therapeutic advances. Preference will be given to proposals that already have a commercial partner engaged to assist with development and to proposals that have committed or matched funding from the sponsoring institution, commercial partner or other third party source. For the New Therapy Commercialization Grants, applicants must demonstrate background work beyond the basic science discovery stage.

Epilepsy Innovation Seal of Excellence

Application deadline: LOIs due March 7, 2016

Instructions and Guidelines

The Epilepsy Innovation Seal of Excellence award is similar to the Epilepsy Foundation - New Therapy Commercialization Grants (NTCG) Program above, designed to accelerate the advancement of research from the laboratory to the patient. SEALs are provided to academic and commercial groups worldwide. The program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. Drug development may be stimulated at the early phases leading to an IND.

The Epilepsy Innovation Seal of Excellence award is not primarily a grant program. The program provides a competitive, in-depth review by the Scientific and Business Advisory Boards and an actual SEAL that may be used by the awardee to generate interest in the project.  A one-time monetary award of $25,000 may be given in recognition of the potential significance of the project in addressing a significant need in epilepsy. The SEAL is awarded for one year, renewable upon application, for up to a total of four years; the funding for this award, if given, is only provided for the first year. The applicants will typically have a research budget of between $1 and $5M for the overall project--amounts that currently exceed the resources of the Epilepsy Foundation. The Epilepsy Foundation will assist the awardees in finding funds for the selected projects.